Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Transgenomic, a global biotechnology company, and US-based PerkinElmer have entered into a collaboration agreement for marketing and distributing Transgenomic’s line of molecular diagnostic oncology products in territories outside the ...
Laboratory Corporation of America Holdings (LabCorp) has announced the nationwide availability of QIAGEN’s therascreen KRAS RGQ PCR kit, a new US Food and Drug Administration (FDA) approved companion diagnostic for certain colorectal ...
Tags: Labcorp, Colorectal Cancer
Quest Diagnostics, a provider of diagnostic information services, has acquired ConVerge Diagnostic Services, a full-service laboratory providing clinical, cytology and anatomic pathology testing services to patients, physicians and ...
The European Medicines Agency (EMA) has received an application from Bayer HealthCare for marketing authorization of its oral multi-kinase inhibitor, regorafenib, for the treatment of patients with gastrointestinal stromal tumors (GlST). ...
Molecular diagnostics company Epigenomics has entered into a €5m convertible bond financing agreement with YA Global Master SPV Ltd. Pursuant to the terms of the agreement, YA Global Master SPV will purchase convertible notes with a ...
Tags: Epigenomics, Molecular diagnostics
MIT researchers have developed a new 3D colonoscopy technology, known as photometric stereo endoscopy, which helps doctors to easily detect precancerous lesions in the colon. The 3D images produced by the new device could lead to earlier ...
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
US-based SpectraScience and Pentax Medical have entered into an expanded distribution deal for an optical biopsy system in Europe. The WavSTAT4 optical biopsy system is designed for use in the screening and diagnosis of colorectal cancer. ...
ARUP Laboratories, a US-based national reference laboratory, has developed a blood-based test for identifying patients with previously undetected colorectal cancer. Designed as an alternative to colonoscopy, the Septin 9 methylated DNA ...
Clinical diagnostics company BioChain has licensed Epigenomics' methylated Septin9 marker, designed for the blood based detection of colorectal cancer (CRC). Under the license, BioChain will offer Septin9 assay as a service to customers ...
Tags: Clinical diagnostics, BioChain, Epigenomics
Lab21 has entered into a collaboration agreement with IntegraGen for the development of a microRNA assay for colorectal cancer. Under the partnership, Lab21 will utilize its proprietary SPARQ PCR technology to develop a CE marked assay ...
Tags: colorectal cancer assay, IntegraGen, microRNA biomarker
Exact Sciences has submitted the second module of premarket application (PMA) of its noninvasive stool DNA colorectal cancer screening test to the US Food and Drug Administration (FDA). The module included the required studies and ...
Tags: FDA, colorectal cancer, clinical trial
Navidea Biopharmaceuticals has collaborated with Maimonides Medical Center to find the use of Lymphoseek (technetium Tc 99m tilmanocept) injection for lymphatic mapping in colorectal cancer. The investigator-initiated study will be ...
Tags: Navidea, Medical Center, medical market
Navidea Biopharmaceuticals has jouned forces with Maimonides Medical Centre to investigate Lymphoseek injections as a potential treatment for colorectal cancer. Dr. Danny Sherwinter, surgeon and the director of the Department of Minimally ...